Teva Pharmaceutical Industries Limited

TEVANYSE • USD
40.96 USD
↘ 0.51 (1.23%)🟢PRE MARKET (AS OF 05:45 AM EDT)
🟢Market: OPEN

Teva Pharmaceutical Industries Limited (TEVA) is currently trading at $40.96. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, a bullish Golden Cross on the moving averages and bullish moving average alignment. TEVA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Oct 29, 2026.

Open?$41.43
High?$41.43
Low?$40.96
Prev. Close?$41.47
Volume?5.8K
Avg. Volume?6.0M
VWAP?$41.22
Rel. Volume?0.00x
Bid / Ask
Bid?$41.00 × 100
Ask?$41.09 × 300
Spread?$0.09
Midpoint?$41.05
Valuation & Ratios
Market Cap?48.4B
Shares Out?N/A
Float?1.2B
Float %?99.6%
P/E Ratio?68.41
P/B Ratio?6.24
EPS?$0.61
Dividend?0.00%
Ex-Dividend?N/A
RelatedABBV
News
Profile
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Employees
32.8K
Market Cap
46.6B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1982-02-16
Address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
TEL AVIV,
Phone: 972 (3) 914-8213
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
10
Momentum?
69
Short Sent.?
83
Piotroski F-Score?4/9Mixed
Altman Z-Score?0.93Distress
Confidence?61%Moderate
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?2.42%Low
Short Interest?28.1M
Days to Cover?3.9
Free Float1.2B
Avg Daily Volume7.2M
Settlement Date2026-10-15
Financial Health
Current Ratio?0.90Weak
Quick Ratio?0.69Weak
Cash Ratio?0.24Low
Debt/Equity?2.14High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
61/100
P/E?
Peers
100
S&P
7
68.4PRICEY▾
P/B?
S&P
29
6.24FAIR▾
P/S?
Peers
100
S&P
53
2.79CHEAP▾
P/FCF?
Peers
50
S&P
20
35.9PRICEY▾
EV/EBITDA?
Peers
100
S&P
54
14.4FAIR▾
EV/Sales?
Peers
100
S&P
53
3.54FAIR▾
Returns & Efficiency
ROE?
S&P
31
9.1%FAIR▾
ROA?
Peers
50
S&P
18
1.8%WEAK▾
Cash Flow & Enterprise
FCF?$1.3B
Enterprise Value?$61.3B
Fundamentals ratios updated end of day